Walter Menzel
Fondatore presso Prostate Management Diagnostics, Inc.
Patrimonio netto: 12 862 $ in data 30/06/2024
Posizioni attive di Walter Menzel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| WM Group | Presidente | - | - |
Peter Michael Foundation
 Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Fondatore | - | - | |
Prostate Management Diagnostics, Inc.
 Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - |
Storia della carriera di Walter Menzel
Precedenti posizioni note di Walter Menzel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
McCann-Erickson USA, Inc.
 McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
| CYANOTECH CORPORATION | Direttore/Membro del Consiglio | 29/08/2013 | - |
| Independent Dir/Board Member | 29/08/2013 | - |
Formazione di Walter Menzel
| Stanford University | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Director/Board Member | 3 |
| Founder | 2 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYANOTECH CORPORATION | Health Technology |
| Aziende private | 4 |
|---|---|
Prostate Management Diagnostics, Inc.
Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Health Technology |
McCann-Erickson USA, Inc.
McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Commercial Services |
| WM Group | |
Peter Michael Foundation
Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Commercial Services |
- Borsa valori
- Insiders
- Walter Menzel
- Esperienza
